Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Pleural Diseases Market Set to Boom Rapidly by 2033 |Bristol Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc
The global Pleural Diseases Market is projected to grow from USD 5.76 billion in 2025 to USD 9.37 billion in 2032, exhibiting a CAGR of 7.2%. This growth is driven by rapid innovation and shifting regional dynamics, with key players including Bristol Myers Squibb, Merck & Co., Inc., and GlaxoSmithKline plc. The market is segmented by disease type, diagnostic tools, treatment modalities, and end-users, and the report provides strategic insights for stakeholders.